KRYS, EXEL, CVS: Beating the Market, with More to Come

Life Science

10-Bagger Potential on the TSX: Two Small-Cap Stocks to Watch Now

Life Science, Technology

Eli Lilly and Intuitive Surgical Are Healthcare Stocks Worth Buying, Thanks to Strong Fundamentals

Life Science

Can BioNTech’s Oncology ‘Ace’ Help It Reclaim the Spotlight?

Life Science

Gene-Editing Pioneer CRISPR Therapeutics Targets the $60 Billion CAR-T Market

Life Science

IBBQ, IXJ, PJP or VHT? A Side-by-Side Look at Four Healthcare ETFs

Life Science

AbbVie Outperforms S&P 500 This Year, With Three Major Long-Term Positive Factors Supporting Future Performance

Life Science

Samsung Electronics Launches AI Health Assistant, Leveraging Ecosystem Advantages to Enter Competitive Red Ocean

Life Science, Technology

Novo Nordisk Sues Eli Lilly Over ‘Deceptive’ GLP-1 Ads, Stock Impact Seen Limited

Life Science

The AI Ebb Gives Way to Biotech as Winners Emerge in the U.S. IPO Market

Life Science

Cathie Wood’s Ark Invest Bets on Beam Therapeutics, with Multiple Clinical Catalysts Expected to Densely Materialize Over the Next 18 Months

Life Science

Up 100% Then Down 24%: Is the Moderna Pullback a Buying Opportunity?

Life Science

Brookfield-Healthpeak $2.1B Deal: Decoding BAM’s Cash-Cow Advantage

Life Science, Real Estate

A 54-Year Dividend Streak Meets a $10.9 Billion Acquisition: Here’s Why AbbVie’s Payouts Are Safe

Life Science

Anti-Cancer Upstart’s Stock Surges 125% This Year as Billionaire Druckenmiller Builds Large Position

Life Science